Customer Validation
- •Cancer Res. 2016 Nov 15;76(22):6631-6642.
- •J Autoimmun. 2017 Jun;80:28-38.
- •Brain Behav Immun. 2017 Jan;59:322-332.
- •Basic Res Cardiol. 2017 Jan;112(1):9.
- •Oncotarget. 2017 May 9;8(19):31802-31814.
- •Oncotarget. 2017 May 2;8(18):29996-30007.
- •Oncotarget. 2017 Mar 28;8(13):21044-21053.
- •Cell Physiol Biochem. 2017 Mar 29;41(4):1675-1683.
- •Sci Rep. 2017 Mar 8;7:43834.
- •Sci Rep. 2017 Mar 8;7:43796.
- •Sci Rep. 2016 Aug 4;6:30957.
- •Sci Rep. 2016 Jun 9;6:27866.
- •J Neurochem. 2017 Oct;143(2):225-235.
- •J Neurochem. 2016 May;137(4):576-88.
- •Exp Cell Res. 2015 Feb 15;331(2):320-30.
- •Mol Pain. 2014 Feb 6;10(1):10.
- •Am J Physiol Gastrointest Liver Physiol. 2016 Dec 1;311(6):G1091-G1104.
- •Am J Physiol Gastrointest Liver Physiol. 2014 Feb;306(3):G244-52.
- •Neuroscience. 2017 Sep 30;360:128-138.
- •Food Funct. 2017 May 24;8(5):1905-1914.
- •Vaccine. 2017 Feb 15;35(7):1037-1045.
- •Vaccine. 2015 Apr 15;33(16):1923-33.
- •Life Sci. 2017 Feb 1;170:25-32.
- •Molecules. 2017 Jul 15;22(7). pii: E1187.
- •PLoS One. 2017 Jul 24;12(7):e0181796.
- •PLoS One. 2017 May 24;12(5):e0178147.
- •Oncol Rep. 2017 Jun;37(6):3341-3350.
- •Vet Microbiol. 2017 May;203:158-166.
- •J Sci Food Agric. 2017 Nov;97(14):4727-4736.
- •Photochem Photobiol. 2016 Nov;92(6):816-825.
- •J Biochem. 2017 Oct 18.
- •Cytotechnology. 2017 Apr;69(2):229-244.
- •BMC Musculoskelet Disord. 2014 Jan 15;15(1):18.
- •Mol Med Rep. 2017 Sep;16(3):3111-3116.
- •Oncol Lett. 2016 Aug;12(2):1034-1040.
- •Biosci Biotechnol Biochem. 2016 Jul;80(7):1393-402.
- •Chin Med J (Engl). 2017 Apr 20;130(8):906-913.
- •University of Arizona. 02-Nov-2017.
- •Biochem Biophys Rep. 2017 Sep;11:147-153.
- •Hainan Med J, Aug. 2017, Vol. 28, No. 15.
- •Chinese Journal of Public Health. 2016, 32(11): 1480-1484.
- •Universität Würzburg. 2016.
- •Seitoku University. 2014.
| Description |
TAK-242 is a potent TLR4 signaling inhibitor, selectively inhibits the TLR4-mediated production of cytokines and NO. |
|---|---|
| IC50 & Target |
TLR4[1] |
| In Vitro |
In RAW264.7 cells and mouse peritoneal macrophages, TAK-242 suppresses lipopolysaccharide (LPS)-induced production of NO, tumor necrosis factor-α (TNF-α), and interleukin (IL)-6, with IC50 of 1.1 to 11 nM. TAK-242 also suppresses the production of these cytokines from LPS-stimulated human peripheral blood mononuclear cells (PBMCs) at IC50 values from 11 to 33 nM[1]. |
| In Vivo |
TAK-242 apparently reduces the serum anti-dsDNA levels in both genotype mice. Alternatively, IFN-γ, TNF-α, and IL-1β production is markedly inhibited by TAK-242, but their concentrations are still greatly higher than those in NS-treated counterparts[2]. TAK-242 pre-stress administration prevents the accumulation of potentially deleterious inflammatory and oxidative/nitrosative mediators in the brain frontal cortex of rats. TAK-242 i.v. administration at the beginning of the stress session completely blocks TLR-4 mRNA and protein upregulation after stress exposure[3]. |
| Clinical Trial |
View MoreCollapse
|
| References |
|
| Preparing Stock Solutions |
Please refer to the solubility information to select the appropriate solvent.
|
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Assay
[1] |
TAK-242 is dissolved in N,N-dimethylformamide, and then diluted with appropriate medium before use[1]. RAW264.7 cells are seeded at a density of 3×106 cells/well in six-well culture plate and incubated overnight. After washing with RPMI 1640 medium supplemented with 1% FCS and 10 μg/mL Kanamycin, the cells are stimulated with 5 ng/mL LPS and 1 U/mL IFN-γ in the presence or absence of TAK-242 (1-100 nM) for the indicated time. Culture supernatants are removed, and total RNA is isolated using the total RNA isolation reagent ISOGEN. Total RNA is reverse transcribed into cDNA by using TaqMan reverse transcription reagents. Quantitative real-time PCR analysis of TNF-α and IL-6 is performed on ABI Prism 7700 using predeveloped TaqMan assay reagents and Universal PCR master mix. Quantitation of mRNA is performed using the comparative threshold cycle method. The highest control level attained by the stimulation (without TAK-242) is regarded as 100%, and the levels of control group at other time points and TAK-242-added group are expressed as the percentage of the highest control level[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
| Animal Administration
[2][3] |
TAK-242 is dissolved in vehicle (saline) (Mice)[2].
Mice[2] |
||||||||||||||||
| References |
|
| Molecular Weight |
361.82 |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Formula |
C₁₅H₁₇ClFNO₄S |
||||||||||||
| CAS No. |
243984-11-4 |
||||||||||||
| Storage |
|
||||||||||||
| Shipping | Room temperature in continental US; may vary elsewhere |
||||||||||||
| Solvent & Solubility |
DMSO: ≥ 360 mg/mL TAK-242 is dissolved in a fat emulsion (i.v. injection)[4]. * "<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">1> |
||||||||||||
| References |
|
Purity: 99.95% ee.: 98.00%
COA (97 KB) HNMR (266 KB) RP-HPLC (236 KB) NP-HPLC (236 KB)
Handling Instructions (1252 KB)-
[1]. Ii M, et al. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
[2]. Ni JQ, et al. Role of toll-like receptor 4 on lupus lung injury and atherosclerosis in LPS-challenge ApoE⁻/⁻ mice. Clin Dev Immunol. 2013;2013:476856.
[3]. Gárate I, et al. Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J Neuroinflammation. 2014 Jan 11;11:8.
[4]. Wang L, et al. Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage. Cancer Res. 2016 Nov 15;76(22):6631-6642.
[5]. Shibata A, et al. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA. J Autoimmun. 2017 Jun;80:28-38.
[6]. Janda J, et al. Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin. Photochem Photobiol. 2016 Nov;92(6):816-825.
[7]. RAO Xiao-jiao, et al. Effect of TLR4 on expression of inflammatory cytokine in aortic artery in mice with insulin resistance[J]. Chinese Journal of Public Health, 2016, 32(11): 1480-1484.
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
求助各位前辈,我最近在合成的化合物水溶性很好,非常好,以至于可以随便溶解在水里,它的六氟磷酸盐也可以随意溶解在水里(大于50uM),细胞成像实验显示它根本进不去细胞,求问有没有啥方法包裹一下让它进去?我搜了一下文献,感觉多数是把脂溶性特别好的东西包裹一下弄进去的,也许是搜索姿势不对没找到我需要的答案,**点拨啊!!!
求助各位大神,现在想购买小分子数据库,求大神推荐。
我知道的免费的数据库有zinc
求推荐哪家公司或者研究所的小分子数据库可以购买,十分感谢!!!!!!
求助大家,小分子药物最新专利申请情况跟踪,之前听别人说可以在一个网站可以导出这个信息。
不知哪位大侠知道,告知一下,不胜感激!
就是蛋白质分子的小片断
是氨基酸形成的
一、首先你要明白肽是什么...........................肽是氨基酸通过酰胺键结合而成的东西.........
二、你要明白氨基酸是什么..........................氨基酸是构成蛋白质的基本单位,多种氨基酸结合为长肽链,几条长肽链再盘旋就形成了蛋白质......................
三、关于小分子肽、短肽、多肽、寡肽.......其实都是肽.......区别只是由多少个氨基酸构成而已............
所以,你的问题可以很粗暴地理解为“蛋白质对人体有没有副作用”.......
如果你营养足够的情况下,再补充这个,会导致营养过剩,从而加重身体代谢的负荷............类似就是这样子的了...........小分子肽,一般现在用于化妆品上比较多(一ye子.植物肽面膜就是这个).......小分子肽(可以简单理解为纳米胶原蛋白),这比蛋白质(也可以粗暴理解为胶原蛋白)更加容易吸收......而用在食品上,要视乎是何种小分子肽了.....大豆肽、花生肽、大米肽....不同的肽有不同的功效.......主要可以改善风味、改善吸收、增强胃肠道功能等等.......
有机的是有机化合物的简称,它指的是含碳化合物.
但是,有四大类常见物质一般不作为有机物处理:
1、碳的氧化物,如CO和CO2.
2、碳酸及其盐,如CaCO3.
3、金属碳化物,如CaC2.
4、拟卤素及其化合物,如(CN)2与KSCN.
水的化学式为H2O,它不含有碳元素,故不是有机物.
但若所描述的水不是化学意义的水,而是自然界存在的天然水,那么,水中会溶有一定量的有机物.



